about
Improvements for international medicine donations: a review of the World Health Organization Guidelines for Medicine Donations, 3rd editionPrescription medicine sharing: exploring patients' beliefs and experiencesThe global intellectual property ecosystem for insulin and its public health implications: an observational study.Drugs for cardiovascular disease in India: perspectives of pharmaceutical executives and government officials on access and development-a qualitative analysisTowards the just and sustainable use of antibioticsForces influencing generic drug development in the United States: a narrative reviewInteraction and medical inducement between pharmaceutical representatives and physicians: a meta-synthesisIs there potential for the future provision of triage services in community pharmacy?Individual capacity-building approaches in a global pharmaceutical systems strengthening program: a selected reviewPromoting transparency, accountability, and access through a multi-stakeholder initiative: lessons from the medicines transparency alliance.Prices and availability of locally produced and imported medicines in Ethiopia and Tanzania.Civil society engagement in multi-stakeholder dialogue: a qualitative study exploring the opinions and perceptions of MeTA membersChallenges of medicines management in the public and private sector under Ghana's National Health Insurance Scheme - A qualitative study.Assessment of the nevirapine safety signal using data from the national antiretroviral dispensing database: a retrospective study.Two years post affordable medicines facility for malaria program: availability and prices of anti-malarial drugs in central Ghana.Comparison of medicines management strategies in insurance schemes in middle-income countries: four case studiesData exclusivity exceptions and compulsory licensing to promote generic medicines in the European Union: A proposal for greater coherence in European pharmaceutical legislation.The effectiveness of naltrexone combined with current smoking cessation medication to attenuate post smoking cessation weight gain: a literature reviewExploring the status of retail private drug shops in Bangladesh and action points for developing an accredited drug shop model: a facility based cross-sectional study.Taking the lead from our colleagues in medical education: the use of images of the in-vivo setting in teaching concepts of pharmaceutical science.Healthcare reform in the United States and China: pharmaceutical market implicationsContribution of antimicrobial stewardship programs to reduction of antimicrobial therapy costs in community hospital with 429 Beds --before-after comparative two-year trial in Japan.Engaging the private sector to improve antimicrobial use in the community: experience from accredited drug dispensing outlets in TanzaniaEffects of the National Essential Medicine System in reducing drug prices: an empirical study in four Chinese provinces.Comparative assessment of medicine procurement prices in the United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA).Occurrence and clinical management of moderate-to-severe adverse events during drug-resistant tuberculosis treatment: a retrospective cohort studyThe availability of six tracer medicines in private medicine outlets in Uganda.Antibiotic repeat prescriptions: are patients not re-filling them properly?Pharmaceutical policy Part 1 The challenge to pharmacists to engage in policy developmentWhat variables should be considered in allocating Primary health care Pharmaceutical budgets to districts in Uganda?The "child size medicines" concept: policy provisions in Uganda.Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand.Medicines and universal health coverage: challenges and opportunitiesPharmaceutical supply chain risk assessment in Iran using analytic hierarchy process (AHP) and simple additive weighting (SAW) methods.Patient access schemes in Asia-pacific markets: current experience and future potentialTuberculosis deaths: are we measuring accurately?Adherence to treatment guidelines for uncomplicated malaria at two public health facilities in Nigeria; Implications for the 'test and treat' policy of malaria case managementPharmaceutical Policy Part 2 Pharmaceutical engagement and policy development: a framework for influenceMalaria treatment policies and drug efficacy in Haiti from 1955-2012.Economics and industry do not mean ethical conduct in clinical trials.
P1433
Q26777385-08DDA252-23F9-4523-9621-796D87B79D6AQ27316487-1B5869A8-34EF-4915-8DE9-A9FCB9D3536EQ27316509-EB9446EF-D556-4419-AC70-E5558FFF6071Q27316535-3D008F40-E418-4B0D-9995-688966E6ECF9Q28067846-6F499EFE-D58D-4D17-A452-E4F6F790E5F9Q28070306-FA6DBCAB-80B7-4A9C-80FB-6A8C0AD49AA9Q28071334-58788F59-3544-4ADE-BBA9-B9CEC4C4F265Q28076534-84FC0608-35A2-4919-818C-9095B8488C58Q29994765-CCD49EEB-EB87-4091-B98A-C501964D31C7Q30376595-9A294F4C-8AAE-45C5-A5B6-623B83630F4DQ30379295-799291B5-58A4-44AB-8E80-7D1764B954E6Q30379541-05E13916-E846-463E-9A9A-1E86211D2627Q30385819-C45B1209-F0BE-435D-8BAE-CE31A95D8F50Q31046220-1714A0E5-92F0-4F8D-837E-C984D674FEFDQ33617936-6396C5E1-8562-4D28-AA5F-1CA71B78F41EQ33697280-889DFFB2-E276-4ECA-9691-064F2A4C6B46Q33851099-E960F138-1A3A-4009-A8D9-6C595353C6B8Q33892368-16B29BEE-8695-4E22-B05F-63FF75738BCEQ33896378-0894FF4C-87D2-4AF0-88F2-E95C674D4DEEQ33909963-2E2434B1-97A0-433F-B879-37581C828A73Q33984685-CFAB22E2-0FFD-45B2-AF69-F05319077352Q34046002-2DF89DC6-19B1-4D88-9E36-D7AB3D12258AQ34255190-EA5E09AB-946C-4EC5-BAFF-7D250831B22FQ34266928-8501C726-3415-42BD-8D57-686EC80EDE4AQ34410462-5389FDCF-2E3F-49BD-A9B9-E5FE6EE6D988Q34447192-E320FC71-103C-41ED-BF2C-703FFCCB9E73Q34769161-10A753E7-4274-43FF-9DA1-0C3083D2186BQ34979237-28A5561D-4FC1-412F-A269-BEA153C6A827Q35114582-762BB0D9-6A6A-4BE5-B5E6-40B2EBEDF440Q35124524-5860E5D8-2EC9-4B57-8A93-3A35FD376ED8Q35125365-41665705-4B92-4B83-A875-B8072F3FD52BQ35128657-0F716112-747A-4F87-874F-E0CC0561702BQ35149420-C696BDAC-E0F4-443F-8F50-885DA6BA782AQ35163282-DCF41B47-3158-4B4E-A1B9-49E16C1EB0BDQ35176587-5D1564BD-BCCC-4C84-B0FE-2EC76F637F99Q35185546-AE573855-C9D9-4620-A3D6-A5F3DCCC7515Q35187677-BAAEBB5B-DAF1-4DB7-8F67-31CC984EB689Q35194134-794BC6BF-1216-4AE3-9E81-36EB169B9FC7Q35198390-B49F345B-4A9D-4412-845E-50CD147CE6E5Q35198434-26627015-CC4C-4078-8EBB-2884332E1DC8
P1433
description
journal
@en
revista científica
@es
wetenschappelijk tijdschrift van BioMed Central
@nl
wissenschaftliche Fachzeitschrift
@de
name
Journal of pharmaceutical policy and practice
@ast
Journal of pharmaceutical policy and practice
@en
Journal of pharmaceutical policy and practice
@es
Journal of pharmaceutical policy and practice
@nl
type
label
Journal of pharmaceutical policy and practice
@ast
Journal of pharmaceutical policy and practice
@en
Journal of pharmaceutical policy and practice
@es
Journal of pharmaceutical policy and practice
@nl
altLabel
J Pharm Policy Pract
@en
Journal of Pharmaceutical Policy and Practice
@en
prefLabel
Journal of pharmaceutical policy and practice
@ast
Journal of pharmaceutical policy and practice
@en
Journal of pharmaceutical policy and practice
@es
Journal of pharmaceutical policy and practice
@nl
P31
P3181
P1055
P1156
21100325142
P1250
P1476
Journal of pharmaceutical policy and practice
@en